170 related articles for article (PubMed ID: 29843216)
1. Transcription factor KLF13 inhibits AKT activation and suppresses the growth of prostate carcinoma cells.
Wang Q; Peng R; Wang B; Wang J; Yu W; Liu Y; Shi G
Cancer Biomark; 2018; 22(3):533-541. PubMed ID: 29843216
[TBL] [Abstract][Full Text] [Related]
2. KLF9, a transcription factor induced in flutamide-caused cell apoptosis, inhibits AKT activation and suppresses tumor growth of prostate cancer cells.
Shen P; Sun J; Xu G; Zhang L; Yang Z; Xia S; Wang Y; Liu Y; Shi G
Prostate; 2014 Jun; 74(9):946-58. PubMed ID: 24737412
[TBL] [Abstract][Full Text] [Related]
3. Kruppel-like transcription factor 13 regulates T lymphocyte survival in vivo.
Zhou M; McPherson L; Feng D; Song A; Dong C; Lyu SC; Zhou L; Shi X; Ahn YT; Wang D; Clayberger C; Krensky AM
J Immunol; 2007 May; 178(9):5496-504. PubMed ID: 17442931
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of lncRNA MIR4435‑2HG and ST8SIA1 expression inhibits the proliferation, invasion and migration of prostate cancer cells
Xing P; Wang Y; Zhang L; Ma C; Lu J
Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33846784
[TBL] [Abstract][Full Text] [Related]
5. Molecular Mechanisms for Krüppel-Like Factor 13 Actions in Hippocampal Neurons.
Ávila-Mendoza J; Subramani A; Sifuentes CJ; Denver RJ
Mol Neurobiol; 2020 Sep; 57(9):3785-3802. PubMed ID: 32578009
[TBL] [Abstract][Full Text] [Related]
6. CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway.
Li L; Hu Y; Chen D; Zhu J; Bao W; Xu X; Chen H; Chen W; Feng R
Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34791506
[TBL] [Abstract][Full Text] [Related]
7. Krüppel-Like Factor 13 Deficiency in Uterine Endometrial Cells Contributes to Defective Steroid Hormone Receptor Signaling but Not Lesion Establishment in a Mouse Model of Endometriosis.
Heard ME; Velarde MC; Giudice LC; Simmen FA; Simmen RC
Biol Reprod; 2015 Jun; 92(6):140. PubMed ID: 25904015
[TBL] [Abstract][Full Text] [Related]
8. Kruppel-like factor 13 acts as a tumor suppressor in thyroid carcinoma by downregulating IFIT1.
Liu Y; Song Y; He Y; Kong Z; Li H; Zhu Y; Liu S
Biol Direct; 2023 Oct; 18(1):65. PubMed ID: 37817224
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway.
Chang YL; Zhou PJ; Wei L; Li W; Ji Z; Fang YX; Gao WQ
Oncotarget; 2015 Sep; 6(27):24017-31. PubMed ID: 26172296
[TBL] [Abstract][Full Text] [Related]
10. SIRPB1 promotes prostate cancer cell proliferation via Akt activation.
Song Q; Qin S; Pascal LE; Zou C; Wang W; Tong H; Zhang J; Catalona WJ; Dhir R; Morrell M; Balasubramani GK; Lu Y; Wang Z
Prostate; 2020 Mar; 80(4):352-364. PubMed ID: 31905248
[TBL] [Abstract][Full Text] [Related]
11. The other face of miR-17-92a cluster, exhibiting tumor suppressor effects in prostate cancer.
Ottman R; Levy J; Grizzle WE; Chakrabarti R
Oncotarget; 2016 Nov; 7(45):73739-73753. PubMed ID: 27650539
[TBL] [Abstract][Full Text] [Related]
12. IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way.
Zhang X; Wang D; Liu B; Jin X; Wang X; Pan J; Tu W; Shao Y
J Exp Clin Cancer Res; 2020 Sep; 39(1):190. PubMed ID: 32938489
[TBL] [Abstract][Full Text] [Related]
13. KLF13 regulates the differentiation-dependent human papillomavirus life cycle in keratinocytes through STAT5 and IL-8.
Zhang W; Hong S; Maniar KP; Cheng S; Jie C; Rademaker AW; Krensky AM; Clayberger C
Oncogene; 2016 Oct; 35(42):5565-5575. PubMed ID: 27041562
[TBL] [Abstract][Full Text] [Related]
14. KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis.
Narla G; DiFeo A; Fernandez Y; Dhanasekaran S; Huang F; Sangodkar J; Hod E; Leake D; Friedman SL; Hall SJ; Chinnaiyan AM; Gerald WL; Rubin MA; Martignetti JA
J Clin Invest; 2008 Aug; 118(8):2711-21. PubMed ID: 18596922
[TBL] [Abstract][Full Text] [Related]
15. SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway.
Luo Z; Wang J; Zhu Y; Sun X; He C; Cai M; Ma J; Wang Y; Han S
Neoplasia; 2021 Oct; 23(10):1037-1047. PubMed ID: 34509929
[TBL] [Abstract][Full Text] [Related]
16. Krüppel-like Factor 13 Is a Major Mediator of Glucocorticoid Receptor Signaling in Cardiomyocytes and Protects These Cells from DNA Damage and Death.
Cruz-Topete D; He B; Xu X; Cidlowski JA
J Biol Chem; 2016 Sep; 291(37):19374-86. PubMed ID: 27451392
[TBL] [Abstract][Full Text] [Related]
17. Kruppel-like Factors 3 Regulates Migration and Invasion of Gastric Cancer Cells Through NF-κB Pathway.
Liang X; Feng Z; Yan R; Liu F; Yin L; Shen H; Lu H; Zhang L
Altern Ther Health Med; 2023 Mar; 29(2):64-69. PubMed ID: 36580668
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-302a Suppresses Tumor Cell Proliferation by Inhibiting AKT in Prostate Cancer.
Zhang GM; Bao CY; Wan FN; Cao DL; Qin XJ; Zhang HL; Zhu Y; Dai B; Shi GH; Ye DW
PLoS One; 2015; 10(4):e0124410. PubMed ID: 25922934
[TBL] [Abstract][Full Text] [Related]
19. Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progression.
Dozmorov MG; Azzarello JT; Wren JD; Fung KM; Yang Q; Davis JS; Hurst RE; Culkin DJ; Penning TM; Lin HK
BMC Cancer; 2010 Dec; 10():672. PubMed ID: 21134280
[TBL] [Abstract][Full Text] [Related]
20. The tumor suppressor Zinc finger protein 471 suppresses breast cancer growth and metastasis through inhibiting AKT and Wnt/β-catenin signaling.
Tao C; Luo J; Tang J; Zhou D; Feng S; Qiu Z; Putti TC; Xiang T; Tao Q; Li L; Ren G
Clin Epigenetics; 2020 Nov; 12(1):173. PubMed ID: 33203470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
